Verticals onDemand Secures $4 Million of Financing from Emergence Capital Partners

Verticals onDemand, the leading provider of Software-as-a-Service (SaaS) CRM solutions for the pharmaceutical and biotechnology industry, has secured $4 million of funding from Emergence Capital Partners. Emergence Capital Partners is a leading venture capital firm that specializes in investing in technology-enabled services companies. Some of Emergence’s other investments include Salesforce.com (CRM), SuccessFactors (SFSF), and HireRight (HIRE).

“Verticals onDemand is capitalizing on two of the next big trends in SaaS – vertical markets and platform-as-a-service,” said Gordon Ritter, general partner of Emergence Capital. “The company’s focus and deep domain expertise in the pharmaceutical and biotech CRM market, unique Force.com platform and development experience, and track record of serving global enterprise customers have quickly made them the market leader.”

This latest funding for Verticals onDemand will be used to accelerate the growth of the company’s flagship VBioPharma™ SaaS CRM application in the life sciences market and to expand the product footprint into other vertical markets. Interest in VBioPharma from large, global pharmaceutical and biotechnology companies and emerging market leaders has grown sharply this year as companies realize the value of a vertical CRM product built on a flexible, scalable platform. Verticals onDemand has signed over 15 new customers in the last ten months.

“In the not so distant past, life sciences companies were in the unfortunate position to have to choose between the lesser of two evils – a generalist SaaS CRM product or an inflexible but vertical client/server application,” said Peter Gassner, president and chief executive officer of Verticals onDemand. “We are seeing success because we deliver the best of both worlds – SaaS flexibility and vertical functionality.”

Verticals onDemand developed its SaaS CRM application to provide a cost-efficient alternative over legacy client/server CRM systems, now considered inflexible, complex, and overly expensive. Built on the Force.com™ platform from salesforce.com, VBioPharma delivers all the advantages of the SaaS model. It combines full-featured functionality for primary care selling, specialty care selling, managed care account executives, and key opinion leader management in a single application, empowering all of the industry’s customer-facing teams to integrate their strategies for optimum success.

About Emergence Capital Partners

Emergence Capital Partners, based in San Mateo, Calif., is the leading venture capital firm focused on early and growth-stage Technology-Enabled Services companies. Its mission is to help build market leaders in partnership with great entrepreneurs. Emergence partners have funded and helped build more than 35 TES companies, more than any other early-stage venture firm. Emergence Capital has assets of over $325 million under management. For more information, visit www.emcap.com.

About Verticals onDemand

Verticals onDemand is the leading provider of Software-as-a-Service (SaaS) CRM applications to the pharmaceutical and biotechnology industry. Founded by software industry veterans, the company combines deep industry domain expertise, CRM deployment experience, and Software as a Service (SaaS) operations savvy with Force.com from salesforce.com, the world’s first multitenant, on-demand platform. Verticals onDemand customers are achieving the fastest time to value through the deployment of fully functional CRM applications that are simple to deploy, inexpensive to operate, and provide a superior user experience.

Verticals onDemand is a privately-held company headquartered in Pleasanton, CA. For more information and online product demonstrations, visit www.verticalsondemand.com.

Contacts

Verticals onDemand, Inc.
Lisa Barbadora, 610-420-3413
pr {at} verticalsondemand(.)com
or
Emergency Capital Partners
Jennifer Deitsch
jdeitsch {at} newventurecom(.)com